Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 601.40
-5.00 (-0.82%)
Aug 8, 2025, 4:59 PM CET
Altus Power Market Cap
Coloplast has a market cap or net worth of 135.42 billion as of August 8, 2025. Its market cap has decreased by -31.56% in one year.
Market Cap
135.42B
Enterprise Value
158.95B
Revenue
27.79B
Ranking
n/a
PE Ratio
29.82
Stock Price
$601.40
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 135.42B, an increase of 2,202.98%. That is a compound annual growth rate of 11.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 135.42B | -23.49% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | 197.71B | 12.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,372.35B |
| Genmab | 88.96B |
| Demant | 54.02B |
| ALK-Abelló | 40.92B |
| H. Lundbeck | 33.40B |
| Ambu A/S | 24.40B |
| Zealand Pharma | 23.11B |
| Bavarian Nordic | 18.53B |